ABBLO PHARMA ApS
CVR 34080534 · Private limited company (ApS) · Active · Very high risk
ABBLO PHARMA ApS is a Private limited company (ApS), founded on , based in Charlottenlund. The company is registered in the industry engroshandel med medicinalvarer og sygeplejeartikler. Our model estimates a bankruptcy risk of 7.8% over the next 12 months, which is 5.6 times the average for Danish companies. 14 annual reports have been published. The latest annual report (31 Dec 2025) shows equity of DKK -238k and a net result of DKK -152k.
Bankruptcy risk for ABBLO PHARMA ApS
5.6 × the average (1.41%) · higher risk than 96% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 34080534
- Status
- Active
- Company type
- Private limited company (ApS)
- Founded
- (14 years)
- Address
- Gotfred Rodes Vej 8
2920 Charlottenlund - Municipality
- Gentofte
- Industry
- Engroshandel med medicinalvarer og sygeplejeartikler (464610)
Bankruptcies in the industry: Engroshandel med andre maskiner og andet udstyr - Share capital
- DKK 80k
- Employees
- 0 (2018)
- Auditor
- PricewaterhouseCoopersStatsautoriseret Revisionspartnerselskab
- Audit opted out
- Yes
Warning signs
| Annual reports filed late | 0 of 14 |
| Missing annual report | No |
| Negative equity | Yes |
| Equity ratio | -20.5% |
| Current ratio | 233% |
| Moves (last 2 years) | 0 |
| CEO changes in total | 1 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 0 |
| Going-concern uncertainty | Yes |
Financials and key figures
| Financial year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Gross profit | DKK 472k | DKK 855k | DKK 1.0m |
| Net profit | DKK -152k | DKK 135k | DKK 107k |
| Equity | DKK -238k | DKK -86k | DKK -221k |
| Total assets | DKK 1.2m | DKK 1.4m | DKK 1.5m |
| Cash | DKK 486k | DKK 542k | – |
| Short-term debt | DKK 499k | DKK 489k | – |
| Avg. employees | 1 | 1 | – |
Latest annual report: Reporting class B · auditor's statement: Andre erklæringer uden sikkerhed · PricewaterhouseCoopersStatsautoriseret Revisionspartnerselskab.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Jan 2025 – 31 Dec 2025 | 166 | ||
| 1 Jan 2024 – 31 Dec 2024 | 122 | ||
| 1 Jan 2023 – 31 Dec 2023 | 55 | ||
| 1 Jan 2022 – 31 Dec 2022 | 89 | ||
| 1 Jan 2021 – 31 Dec 2021 | 56 | ||
| 1 Jan 2020 – 31 Dec 2020 | 84 | ||
| 1 Jan 2019 – 31 Dec 2019 | 99 | ||
| 1 Jan 2018 – 31 Dec 2018 | 123 | ||
| 1 Jan 2017 – 31 Dec 2017 | 82 | ||
| 1 Jan 2016 – 31 Dec 2016 | 160 | ||
| 1 Oct 2014 – 31 Dec 2015 | 153 | ||
| 1 Oct 2013 – 30 Sep 2014 | 58 | ||
| 1 Oct 2012 – 30 Sep 2013 | 168 | ||
| 13 Dec 2011 – 30 Sep 2012 | 110 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Nic Borch-Christensen | ||
| Board | Nic Borch-Christensen | Current | |
| Board | Mie Hjerrild Petersen | Current | |
| Owner (100%) | ABBLO S.à.r.l | Current | |
| Auditor | DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB | ||
| Auditor | Beierholm Godkendt Revisionspartnerselskab | ||
| Founder | Nic Borch-Christensen | Current |
The CEOs' other companies
Nic Borch-Christensen – 2 other companies, of which 1 bankrupt
- Aktieselskabet af 14. februar 2020 Bankrupt 21 Feb 2020
- EJENDOMSANPARTSSELSKABET AF 13.12.1976 Opløst
Address history (1 moves)
| Gotfred Rodes Vej 8, 2920 Charlottenlund | |
| Grenågade 5, 4. th, 2100 København Ø |
Former names
| ABBLO PHARMA ApS | – now |
| NHBC HOLDING ApS | – |
Employees per year
Similar companies in Gentofte
- GastroBiome Delivery ApS Charlottenlund
- BioAgeDiagnostics ApS Charlottenlund
- MC ASPA ApS Charlottenlund
- Resqsupply ApS Gentofte
- Ascendis Pharma Europe A/S Hellerup
- Circius Pharma ApS Hellerup
- Valida Health ApS Hellerup
- Cordane International ApS Hellerup
- AJB Consult ApS Hellerup
- Chr. Olesen Pharma Latin A/S Gentofte
- Winmed A/S Hellerup
- Novivitae ApS Gentofte
Questions and answers about ABBLO PHARMA ApS
Has ABBLO PHARMA ApS gone bankrupt?
No, ABBLO PHARMA ApS is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of ABBLO PHARMA ApS?
Our model estimates a bankruptcy risk of 7.8% over the next 12 months (very high risk), which is 5.6 times the average for Danish companies.
Who is the auditor of ABBLO PHARMA ApS?
ABBLO PHARMA ApS most recently used PricewaterhouseCoopersStatsautoriseret Revisionspartnerselskab.
When was ABBLO PHARMA ApS founded?
ABBLO PHARMA ApS was founded on 13 December 2011.
What is the equity of ABBLO PHARMA ApS?
Equity was DKK -238k according to the annual report for the period ending 31 December 2025.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.